Compounds > gusperimus
Page last updated: 2024-08-23

gusperimus and Glomerulonephritis, Lupus

gusperimus has been researched along with Glomerulonephritis, Lupus in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexander, T; Hauser, IA; Heinzel, PA; Hiepe, F; Lorenz, HM; Müller-Ladner, U; Nemoto, K; Schmitt, WH; Tarner, I; Tesar, V; Woehling, H1
Grunke, M; Heinzel, PA; Kalden, JR; Lorenz, HM; Wendler, J1
Amemiya, K; Inoue, K; Kamata, K; Kobayashi, N; Masaki, Y; Okubo, M1
Amemiya, K; Inoue, K; Kamata, K; Masaki, Y; Okubo, M; Tamura, K1
Aoyagi, T; Arakawa, M; Fujiwara, M; Ito, S; Saito, T; Ueno, M1
Aoyagi, T; Inoue, K; Kamata, K; Masaki, Y; Okubo, M; Sato, N; Shirai, T; Uchiyama, T; Umetani, N; Yan, XJ1
Abe, F; Hayashi, M; Ito, J; Nakamura, T; Nemoto, K; Sugawara, Y; Takeuchi, T; Takita, T1

Trials

1 trial(s) available for gusperimus and Glomerulonephritis, Lupus

ArticleYear
Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.
    Arthritis research & therapy, 2011, Mar-01, Volume: 13, Issue:2

    Topics: Adult; Female; Guanidines; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Pilot Projects; Young Adult

2011

Other Studies

6 other study(ies) available for gusperimus and Glomerulonephritis, Lupus

ArticleYear
Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus.
    Annals of the rheumatic diseases, 2005, Volume: 64, Issue:10

    Topics: Adult; Female; Guanidines; Humans; Immunosuppressive Agents; Lupus Nephritis; Middle Aged; Opportunistic Infections

2005
High-dose 15-deoxyspergualin monotherapy surpasses methylprednisolone in its therapeutic effect on advanced lupus nephritis in New Zealand black/white F1 hybrid mice, and low-dose combination may be synergistic.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1993, Volume: 8, Issue:8

    Topics: Animals; Drug Synergism; Drug Therapy, Combination; Female; Guanidines; Hybridization, Genetic; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB

1993
Effect of 15-deoxyspergualin on lupus nephropathy in New Zealand black/white F1 mice.
    Nephron, 1992, Volume: 60, Issue:3

    Topics: Animals; Body Weight; Female; Flow Cytometry; Fluorescent Antibody Technique; Guanidines; Immunoglobulin G; Immunosuppressive Agents; Interleukin-2; Kidney Glomerulus; Lupus Nephritis; Mice; Mice, Inbred Strains; Spleen; T-Lymphocytes

1992
Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.
    Clinical and experimental immunology, 1990, Volume: 81, Issue:3

    Topics: Animals; Antigen-Antibody Complex; Autoantibodies; B-Lymphocytes; Chi-Square Distribution; Complement C3; Depression, Chemical; DNA; Female; Guanidines; Immunoglobulin G; Immunosuppressive Agents; Kidney Glomerulus; Lupus Nephritis; Lymphocyte Activation; Male; Mice; Mice, Inbred Strains; Spleen

1990
Lupus nephropathy in New Zealand F1 hybrid mice treated by (-)15-deoxyspergualin.
    Kidney international, 1988, Volume: 34, Issue:4

    Topics: Age Factors; Animals; Antibody Formation; Body Weight; Female; Guanidines; Immunosuppressive Agents; Kidney Glomerulus; Lupus Nephritis; Mice; Mice, Inbred NZB; Spleen

1988
Biological activities of deoxyspergualin in autoimmune disease mice.
    The Journal of antibiotics, 1988, Volume: 41, Issue:9

    Topics: Animals; Anthraquinones; Antibodies, Antinuclear; Autoimmune Diseases; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Guanidines; Immunosuppressive Agents; Lupus Nephritis; Male; Mice

1988